BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29109779)

  • 1. Serum Immune Profiling for Early Detection of Cervical Disease.
    Ewaisha R; Panicker G; Maranian P; Unger ER; Anderson KS
    Theranostics; 2017; 7(16):3814-3823. PubMed ID: 29109779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia.
    Chay DB; Cho H; Kim BW; Kang ES; Song E; Kim JH
    Obstet Gynecol; 2013 Feb; 121(2 Pt 1):321-329. PubMed ID: 23344282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
    Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
    BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia.
    De Sanjosé S; Hamsíková E; Muñoz N; Bosch FX; Hofmannová V; Gili M; Izarzugaza I; Viladiu P; Tormo MJ; Moreo P; Muñoz MT; Ascunce N; Tafur L; Shah KV; Vonka V
    Int J Cancer; 1996 Mar; 66(1):70-4. PubMed ID: 8608970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of antibody to E2 protein of human papillomavirus and p16
    Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
    Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia.
    Tabrizi SN; Frazer IH; Garland SM
    Int J Gynecol Cancer; 2006; 16(3):1032-5. PubMed ID: 16803481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
    Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
    Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of human papillomavirus infection in paraffin-embedded cervical tissues by gene clip technology].
    Lü YL; Zhong M; Zhao P
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):719-21. PubMed ID: 17374254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of the human papillomavirus 16/18 E7 protein assay in screening for cervical intraepithelial neoplasia: a case control study.
    Kong L; Xiao X; Lou H; Liu P; Song S; Liu M; Xu T; Zhang Y; Li C; Guan R; Li Y; Yu X; Liu H; Fan Q; Shi H; Zhu L
    BMC Cancer; 2020 Oct; 20(1):999. PubMed ID: 33054783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic response in human papillomavirus-associated invasive cervical cancer.
    Viscidi RP; Sun Y; Tsuzaki B; Bosch FX; Muñoz N; Shah KV
    Int J Cancer; 1993 Nov; 55(5):780-4. PubMed ID: 8244575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
    Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
    J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable protein arrays for immunoprofiling HPV-associated cancers.
    Ewaisha R; Meshay I; Resnik J; Katchman BA; Anderson KS
    Proteomics; 2016 Apr; 16(8):1215-24. PubMed ID: 27089055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.